Jazz Pharmaceuticals plc - FORM 10-Q - EX-10.55 - 2010 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS - May 5, 2010

Attached files

file	filename
10-Q - FORM 10-Q - Jazz Pharmaceuticals plc	d10q.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plc	dex312.htm
EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plc	dex321.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plc	dex311.htm
EX-10.13 - LICENSE AGREEMENT - Jazz Pharmaceuticals plc	dex1013.htm
EX-10.54 - SUPPLY AGREEMENT - Jazz Pharmaceuticals plc	dex1054.htm

Exhibit 10.55

2010 Executive Officer Compensation Arrangements


Executive Officer		2010 Base Salary Rate			2010 Target Bonus as % of Annual Base Salary Rate

Bruce C. Cozadd Chairman and Chief Executive Officer		$	500,000.00		60

Robert M. Myers President		$	448,000.00		50

Kathryn E. Falberg Senior Vice President and Chief Financial Officer		$	365,000.00		40

Carol A. Gamble Senior Vice President, General Counsel and Corporate Secretary		$	361,000.00		40

Joan E. Colligan Controller and Principal Accounting Officer		$	217,250.00		10 -30